36 completed, 7 terminated, 6 recruiting, 6 unknown. 19 Not applicable, 17 Phase 3, 12 Phase 2, 4 Phase 1, 4 Phase 4.
Follow Nausea and Vomiting: new trials by email Literature Review of Nausea and Vomiting trials Research Report on Nausea and Vomiting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide Fosaprepitant for Injection, Metoclopramide Injection - Nausea and Vomiting, Nausea | Phase 4 | Not yet recruiting | Montefiore Medical Center | 212 | 2026-12-01 | 2026-06-29 |
| A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use Tradipitant, Placebo - Nausea and Vomiting, Obesity | Phase 3 | Recruiting | Vanda Pharmaceuticals | 280 | 2026-03-27 | 2026-04-20 |
| Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis Olanzapine (dose comparison: 2.5 mg, 5 mg, 10 mg) - Solid Tumours, Olanzapine | Completed | Shandong Cancer Hospital and Institute | 2493 | 2026-01-18 | 2026-09-09 | |
| Dexmedetomidine and Propofol for Sedation in Cataract Surgery. Dexmedetomidine (DEX), Propofol (PRO), Fentanyl (FEN) - Sedation, Cataract | Not applicable | Recruiting | Saint-Joseph University | 1000 | 2025-11-09 | 2026-04-29 |
| Exploring the Effect of Aromatherapy Aromatherapy plus standard of care, Standard of Care Only - Anxiety, Labor Pain | Not applicable | Completed | Baptist Health South Florida | 138 | 2025-10-15 | 2026-10-06 |
| Prevalence of Hyperemesis Gravidarum Nausea and Vomiting | Completed | University Hospital, Clermont-Ferrand | 619 | 2025-05-01 | 2026-10-27 | |
| Antiemetic Fosaprepitant To Remedy Nausea and Vomiting Fosaprepitant 150 mg, Ondansetron 4 mg - Nausea and Vomiting, Nausea | Phase 2 / Phase 3 | Recruiting | Montefiore Medical Center | 200 | 2024-11-13 | 2026-05-18 |
| Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer Electroacupuncture, Antiemetic Therapy, Sham electroacupuncture - Electroacupuncture, Olanzapine-contained Four-drug Antiemetic | Phase 3 | Recruiting | Feixue Song | 370 | 2024-03-07 | 2024-03-21 |
| the Efficacy and Safety of Ondansetron Oral Soluble Pellicles Ondansetron Oral Soluble Pellicles - Nausea and Vomiting | Phase 3 | Unknown | The First Affiliated Hospital of Xinxiang Medical College | 184 | 2024-02-20 | 2024-02-28 |
| Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer Electroacupuncture, Standard antiemetic treatment, Sham electroacupuncture - Electroacupuncture, Olanzapine-contained Four-drug Antiemetic | Phase 3 | Recruiting | Jiuda Zhao | 370 | 2024-01-16 | 2025-04-02 |
| Effect of Glycopyrrolate on Nausea and Vomiting After ERCP Operation Glycopyrrolate, Anisodamine - Nausea and Vomiting | Phase 1 / Phase 2 | Completed | Jie Chen | 130 | 2023-10-01 | 2024-09-05 |
| A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting Heptaflurane combined Cyclophenol, Heptaflurane, Cyclophenol - Nausea and Vomiting | Phase 1 | Unknown | Mengchang Yang | 300 | 2023-08-02 | 2023-07-27 |
| Efficacy of Three Antiemetics in Preventing Nausea and Vomiting tropisetron, metoclopramide, dexamethasone - Nausea and Vomiting | Phase 4 | Completed | The Second Affiliated Hospital of Chongqing Medical University | 200 | 2022-09-15 | 2024-04-02 |
| The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV Palonosetron hydrochloride capsules - Nausea and Vomiting | Not applicable | Recruiting | Xijing Hospital | 1060 | 2022-05-16 | 2023-01-19 |
| The Impact of Oral Cryotherapy and Chewing Gum Interventions Oral Cryotherapy Group (Group 1), Chewing Gum Group (Group 2) - Breast Cancer, Nausea and Vomiting | Not applicable | Completed | Hacettepe University | 135 | 2021-06-01 | 2025-08-28 |
| Effect of Inhaled Aromatherapy on Chemo-Induced Nausea Vomiting (NCVI): CINVAROM (Chemotherapy Induced Nausea Vomiting and AROMatherapy) Essential oils - Nausea and Vomiting, Aromatherapy | Phase 2 | Completed | Centre Francois Baclesse | 96 | 2020-12-14 | 2026-08-17 |
| Effect of Ultrasound-guided Transversus Abdominis Plane Block After Laparoscopic Bariatric Surgery Ropivacaine - Nausea and Vomiting, Laparoscopic Bariatric Surgery | Phase 2 | Unknown | Tianjin Medical University General Hospital | 120 | 2020-09-25 | 2021-08-23 |
| The Preventive Effects of Sub Hypnotic Dose of Propofol for Nausea and Vomiting Induced by Hemabate Propofol, Normal saline - Nausea and Vomiting | Phase 4 | Completed | West China Second University Hospital | 60 | 2017-06-28 | 2018-10-23 |
| Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy Olanzapine, Chemotherapy (cisplatin or cyclophosphamide and doxorubicin), Antiemetic treatment (ondansetron or granisetron or palonosetron; plus dexamethasone; plus fosaprepitant or aprepitant) - Hematopoietic/Lymphoid Cancer, Nausea and Vomiting | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 401 | 2014-08-20 | 2025-01-28 |
| Comparison of the Effect of Ondansetron and Combined Ondansetron and Betahistine on Postoperative Nausea and Vomiting After Gynecological Laparoscopy ondansetron, ondansetron-betahistine - Nausea and Vomiting | Not applicable | Completed | Yonsei University | 168 | 2013-12-01 | 2019-03-28 |
Showing 20 of 60. Sign in to see all of them.
Nausea (60) · Vomiting (60) · Breast Neoplasms (11) · Pain (9) · Fatigue (7) · Anxiety Disorders (6) · Ovarian Neoplasms (5) · Burkitt Lymphoma (4) · Colonic Neoplasms (4) · Colorectal Neoplasms (4) · Hodgkin Disease (4) · Leukemia (4) · Leukemia, Hairy Cell (4) · Leukemia, Lymphocytic, Chronic, B-Cell (4) · Leukemia, Myeloid, Acute (4)
Pathological Conditions, Signs and Symptoms (60) · Signs and Symptoms (60) · Signs and Symptoms, Digestive (59) · Neoplasms by Site (27) · Neoplasms (26) · Neurologic Manifestations (12) · Breast Diseases (11) · Skin Diseases (11) · Skin and Connective Tissue Diseases (11) · Neoplasms by Histologic Type (10) · Digestive System Diseases (8) · Digestive System Neoplasms (8) · Endocrine Gland Neoplasms (8) · Endocrine System Diseases (8) · Gastrointestinal Diseases (8)
Ondansetron (13) · Dexamethasone (12) · Aprepitant (8) · Granisetron (8) · Palonosetron (7) · Calcium Dobesilate (5) · Cyclophosphamide (4) · Radiotherapy (4) · Therapeutics (4) · dexamethasone acetate (4) · Cisplatin (3) · Metoclopramide (3) · dexamethasone 21-phosphate (3) · dolasetron (3) · fosaprepitant (3)
Alliance for Clinical Trials in Oncology (5) · City of Hope Medical Center (3) · Gary Morrow (2) · GlaxoSmithKline (2) · Gynecologic Oncology Group (2) · Montefiore Medical Center (2) · NCIC Clinical Trials Group (2) · OHSU Knight Cancer Institute (2) · University of Washington (2) · Wake Forest University Health Sciences (2) · Albert Einstein College of Medicine (1) · Baptist Health South Florida (1) · Barbara Ann Karmanos Cancer Institute (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Centre Francois Baclesse (1)
United States (33) · China (10) · Canada (3) · France (2) · Italy (2) · South Korea (2) · Switzerland (2) · United Kingdom (2) · Argentina (1) · Austria (1) · Belgium (1) · Chile (1) · Croatia (1) · Czechia (1) · Hong Kong (1)
Gary R. Morrow, PhD, MS (3) · Joseph Bubalo, PharmD, BCPS, BCOP (2) · Marcia Grant, RN, DNSc, FAAN (2) · Alex Molassiotis, MD (1) · Alyson Moadel (1) · Andrea Bezjak, MD, MSC, FRCPC (1) · Barbara A. Murphy, MD (1) · Benjamin Friedman, MD (1) · Benjamin W Friedman, MD MS (1) · Betty Chan (1) · Bruno Gagnon, MD, MSC (1) · Christine M. Walko, PharmD, BCOP (1) · Daniel T Wu, MD (1) · David P. Dearnaley, MD, FRCP, FRCR (1)
PMID 11773155, PMID 12377323, PMID 12562658, PMID 12906958, PMID 16198982, PMID 17785709, PMID 19134445, PMID 22245954, PMID 26289588, PMID 26921245, PMID 27410922, PMID 33993473
P30CA033572 (3), U10CA031946 (2), U10CA101165 (2), P30CA013330 (1), P30CA014089 (1), P30CA016086 (1), P30CA022453 (1), P30CA046592 (1), P30CA069533 (1), R03CA088598 (1)